| |
| |
|
| Insider
Information: |
Luo Mary Z. |
| Relationship: |
COO,Chief Scientist & ... |
| City: |
Rancho Cucamonga |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
2,433,554 |
|
|
Indirect Shares
|
8,057,435 |
|
|
| Direct
Value |
$102,744,650 |
|
|
|
Indirect Value
|
$340,184,906 |
|
|
| Total
Shares |
10,490,989 |
|
|
| Total
Value |
$442,929,556 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amphastar Pharmaceuticals, Inc. |
AMPH |
COO,Chief Scientist & ... |
2024-03-17 |
2,433,554 |
2024-03-17 |
8,057,435 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
I/I |
34,301 |
1,532,820 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2018-12-12 |
4 |
S |
$21.21 |
$794,736 |
I/I |
(37,469) |
7,357,368 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2015-06-12 |
4/A |
AS |
$16.17 |
$621,972 |
I/I |
(38,471) |
679,750 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2015-06-12 |
4 |
AS |
$16.17 |
$621,972 |
I/I |
(38,471) |
665,418 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
• • • |
2019-03-15 |
4 |
A |
$0.00 |
$0 |
I/I |
41,522 |
1,432,112 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2018-03-15 |
4 |
A |
$0.00 |
$0 |
I/I |
41,687 |
1,372,333 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-05-19 |
4 |
AS |
$33.76 |
$1,408,761 |
D/D |
(41,730) |
2,114,793 |
0 |
% |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2015-06-12 |
4 |
OE |
$12.97 |
$547,632 |
I/I |
42,223 |
703,889 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2015-06-12 |
4/A |
OE |
$12.97 |
$547,632 |
I/I |
42,223 |
718,221 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2018-12-14 |
4 |
S |
$20.48 |
$892,309 |
D/D |
(43,577) |
2,072,317 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2015-06-05 |
4 |
AS |
$16.47 |
$724,310 |
I/I |
(43,989) |
667,839 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2015-06-05 |
4 |
AS |
$16.46 |
$726,878 |
D/D |
(44,149) |
916,467 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO and Chief Scientist |
• • • |
2015-06-15 |
4 |
AS |
$16.29 |
$739,445 |
D/D |
(45,382) |
916,315 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2015-06-05 |
4 |
OE |
$12.97 |
$635,271 |
D/D |
48,980 |
960,616 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO and Chief Scientist |
• • • |
2015-06-15 |
4 |
OE |
$12.97 |
$649,291 |
D/D |
50,061 |
961,697 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2015-06-05 |
4 |
OE |
$12.97 |
$650,601 |
I/I |
50,162 |
711,828 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-05-17 |
4 |
AS |
$35.74 |
$1,801,440 |
D/D |
(50,376) |
2,223,569 |
0 |
% |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2015-03-26 |
4 |
A |
$0.00 |
$0 |
I/I |
53,511 |
670,307 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
• • • |
2016-09-21 |
4 |
AS |
$20.70 |
$1,140,334 |
D/D |
(55,081) |
1,088,335 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
• • • |
2016-09-21 |
4 |
OE |
$16.75 |
$922,772 |
D/D |
55,081 |
1,143,416 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2021-03-17 |
4 |
A |
$0.00 |
$0 |
I/I |
56,892 |
1,488,371 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2024-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
64,310 |
2,143,028 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2018-12-11 |
4 |
S |
$21.43 |
$1,433,150 |
I/I |
(66,757) |
7,394,837 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-05-18 |
4 |
AS |
$33.97 |
$2,289,101 |
D/D |
(67,046) |
2,156,523 |
0 |
% |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2017-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
67,415 |
819,736 |
0 |
- |
|
170 Records found
|
|
Page 5 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
